Semaglutide + Pyridoxine: produced with an unauthorized active pharmaceutical ingredient
Last updated
Summary
Product
Create Compounding Pharmacy - Semaglutide + Pyridoxine
Issue
Health products - Product quality
What to do
Consult your healthcare provider for any health concerns.
Distribution
National
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot numbers |
|---|---|---|---|---|---|
N/A |
Semaglutide + Pyridoxine |
N/A |
syringe or vial |
Semaglutide 1mg/mL + Pyridoxine 15mg/mL |
N/A |
N/A |
Semaglutide + Pyridoxine |
N/A |
syringe or vial |
Semaglutide 2 mg/mL + Pyridoxine 30 mg/mL |
N/A |
Issue
The product was produced with an unauthorized active pharmaceutical ingredient.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: End Users
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Create Compounding Pharmacy
130, 7121 107th Ave SE
Calgary, AB
T2C 5N6
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type I
Identification number
RA-76830
Get notified
Receive emails about new and updated recall and safety alerts.